z-logo
open-access-imgOpen Access
Impact of single atrial fibrillation catheter ablation on implantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies
Author(s) -
Jędrzej Kosiuk,
Sotirios Nedios,
Angeliki Darma,
Sascha Rolf,
Sergio Richter,
Arash Arya,
Christopher Piorkowski,
Thomas Gaspar,
Philipp Sommer,
Daniela Husser,
Gerhard Hindricks,
Andreas Bollmann
Publication year - 2014
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/euu018
Subject(s) - medicine , cardiology , catheter ablation , atrial fibrillation , ejection fraction , ablation , implantable cardioverter defibrillator , cardiomyopathy , ischemic cardiomyopathy , heart failure
Atrial fibrillation (AF) is associated with frequent appropriate and inappropriate implantable cardioverter defibrillator (ICD) therapies. Catheter ablation of AF has been shown to reduce AF burden and improve left ventricular function in heart failure patients but the impact on ICD therapies has not yet been studied. The aim of this study was to test the hypothesis that AF ablation reduces ICD therapies in patients with cardiomyopathies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom